Planet G, Fox I H
J Biol Chem. 1976 Oct 10;251(19):5839-44.
The effects of purine nucleosides on 5-phosphoribosylpyrophosphate (PP-ribose-P) synthesis were investigated in human erythrocytes in vitro. Previous observations have shown an increase of PP-ribose-P formation with nucleoside when inorganic phosphate (Pi) exceeded 20 mM. In contrast, when external Pi varied from 0 to 25 mM adenosine, inosine, guanosine, or 6-methylmercaptopurine riboside 1.25 mM decreased intracellular PP-ribose-P. The mechanism of this nucleoside effect on P-ribose-P concentration was investigated. Decreased synthesis rather than increased utilization accounted for the nucleoside effect. A decrease of erythrocyte Pi from the control values of 0.5 to 2.4 mM accompanied the nucleoside-related diminution of PP-ribose-P synthesis. This reduction of Pi was capable of decreasing the activity of PP-ribose-P synthetase which is known to be sensitive to small changes of Pi. The decrease of erythrocyte Pi levels was caused both by those nucleosides which were eventually degraded via purine nucleoside phosphorylase (adenosine, inosine, and guanosine) and by those nucleosides which were substantially phosphorylated initially by adenosine kinase (methylmercaptopurine riboside and adenosine with erythro-9(2-hydroxyl-3-nonyl)-adenine). Twenty-five per cent of methylmercaptopurine riboside was converted to the monophosphate derivative during the incubation. The presence of this compound, capable of inhibiting PP-ribose-P synthetase, provided evidence for a second mechanism of inhibition of PP-ribose-P synthesis by methylmercaptopurine riboside. No substantial increase of AMP, ADP, 2,3-diphosphoglycerate, or cyclic AMP nor a decrease of ribose 5-phosphate was found. These observations suggest that under physiological Pi concentrations nucleosides diminish PP-ribose-P synthesis mainly by decreasing intracellular Pi. Regulation of PP-ribose-P formation by alterations of intracellular Pi levels may be an important control mechanism and may account for a number of biological effects of nucleosides.
在体外对人红细胞中嘌呤核苷对5 - 磷酸核糖焦磷酸(PP - 核糖 - P)合成的影响进行了研究。先前的观察表明,当无机磷酸盐(Pi)超过20 mM时,核苷会使PP - 核糖 - P的形成增加。相反,当外部Pi在0至25 mM之间变化时,1.25 mM的腺苷、肌苷、鸟苷或6 - 甲基巯基嘌呤核糖核苷会降低细胞内PP - 核糖 - P的水平。对这种核苷对P - 核糖 - P浓度影响的机制进行了研究。核苷的影响是由于合成减少而非利用增加所致。随着与核苷相关的PP - 核糖 - P合成减少,红细胞Pi从对照值0.5至2.4 mM降低。Pi的这种降低能够降低已知对Pi的微小变化敏感的PP - 核糖 - P合成酶的活性。红细胞Pi水平的降低是由那些最终通过嘌呤核苷磷酸化酶降解的核苷(腺苷、肌苷和鸟苷)以及那些最初被腺苷激酶大量磷酸化的核苷(甲基巯基嘌呤核糖核苷和与erythro - 9(2 - 羟基 - 3 - 壬基) - 腺嘌呤一起的腺苷)引起的。在孵育过程中,25%的甲基巯基嘌呤核糖核苷转化为单磷酸衍生物。这种能够抑制PP - 核糖 - P合成酶的化合物的存在,为甲基巯基嘌呤核糖核苷抑制PP - 核糖 - P合成的第二种机制提供了证据。未发现AMP、ADP、2,3 - 二磷酸甘油酸或环AMP有实质性增加,也未发现5 - 磷酸核糖减少。这些观察结果表明,在生理Pi浓度下,核苷主要通过降低细胞内Pi来减少PP - 核糖 - P的合成。通过改变细胞内Pi水平来调节PP - 核糖 - P的形成可能是一种重要的控制机制,并且可能解释核苷的许多生物学效应。